MedTrace Logo

Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer

NCT02184663 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 313

Last updated 2023-09-28

No results posted yet for this study

Summary

Adapted Physical Activity (APA) program may provide an opportunity to improve symptoms for patients with unresectable pancreatic cancer.

Thereby, it is proposed to conduct an open trial to assess effects of the APA program in such population

Conditions

Interventions

OTHER

without APA program

Control Arm : chemotherapy alone

OTHER

APA program

Experimental Arm : chemotherapy + APA program during 16 weeks (aerobic and muscular strength exercises)

Sponsors & Collaborators

  • GERCOR - Multidisciplinary Oncology Cooperative Group

    lead OTHER

Principal Investigators

  • Pascal Hammel, MD · Hôpital Beaujon

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-20
Primary Completion
2022-04-21
Completion
2023-12-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02184663 on ClinicalTrials.gov